氨酸通过 lncRNA CBR3-AS1 影响骨髓瘤细胞的免疫活性
Wenpeng Xie1, Fengjun Ma2, Luming Dou3
1Department of Orthopedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250014, China.
Heliyon
|July 1, 2024
概括
氨酸通过向CBR3-AS1/miR-145-5p/GRP78通路来增强骨髓瘤 (OS) 免疫活性和亡. 这项研究提供了对艾利辛的证据.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤 (OS) 是一种具有复杂免疫活性的原发性骨恶性瘤.
- 了解OS进展和免疫逃避背后的分子机制对于开发有效疗法至关重要.
研究的目的:
- 为了研究素对骨髓瘤细胞免疫活性的影响.
- 阐明长非编码RNA (lncRNA) CBR3-AS1/miR-145-5p/GRP78轴在素作用机制中的作用.
- 为艾利作为OS中的免疫调节剂提供潜在的临床证据.
主要方法:
- 在体外研究中,使用 Saos-2 人类 OS 细胞系治疗了不同度的素.
- 感染CBR3-AS1异常表达载体以评估其对OS细胞的影响.
- 救援实验以验证CBR3-AS1/miR-145-5p/GRP78轴内的监管关系.
- 在裸体小鼠的体内瘤生成实验中,评估艾利对瘤生长和T淋巴细胞子集的影响.
主要成果:
- 阿利治疗降低了Saos-2细胞活性,并以剂量依赖的方式增加了亡.
- 氨酸调节了关键分子的表达:降低CBR3-AS1和GRP78,同时增加miR-145-5p.
- 沉默CBR3-AS1模仿了阿利的作用,减少了细胞活性,增强了细胞亡,线粒和内细胞网膜压力.
- 救援实验证实了调节轴:CBR3-AS1通过miR-145-5p影响OS细胞,miR-145-5p的影响由GRP78.8介导.
- 在体内研究表明,氨酸和确定的分子轴调节瘤生长,氨酸激活CD4+CD8+T细胞,表明增强的免疫活性.
结论:
- 阿利有效地激活骨髓瘤免疫活性,并诱导亡.
- 该机制涉及对lncRNA CBR3-AS1/miR-145-5p/GRP78分子轴的调制.
- 这些发现支持阿利因作为治疗骨髓瘤的治疗剂的潜力,通过增强抗瘤免疫力.
更多相关视频
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.1K
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.6K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
